Clinical Trials Sponsored by Jiangsu Kanion Pharmaceutical Co.

Total 367 results

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Not yet recruiting

Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children

Acute Bronchitis in Children
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Healthy Volunteers | Hepatic Impairment

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male Volunteers

Healthy Volunteers

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Epilepsy | Focal-Onset Seizure

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients

Breast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene Mutation

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

Bronchitis

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

Healthy Volunteers

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation (mCRPC)

Metastatic Castration Resistant Prostate Cancer
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia

Mycoplasma Pneumoniae Pneumonia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)

COVID-19
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

Study of Aolanti Weikang Tablets in Healthy Volunteers

Functional Dyspepsia

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Study of SC10914 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Not yet recruiting

A Phase I Study of BR790 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer

Advanced Ovarian Cancer

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia

2019 Novel Coronavirus Pneumonia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children

Community Acquired Pneumonia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients

Functional Dyspepsia

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis

Acute Tonsillitis

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

Acute Bronchitis

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

Acute Exacerbation of Chronic Bronchitis

China
Jinling hospital Nanjing, Jiangsu, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Recruiting

A Study of TH-SC01 in the Treatment of Radiation-induced Rectal Injury

Rectal Injury

China
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
Wuhan Union Hospital, China
Jiangsu HengRui Medicine Co., Ltd.; CSPC ZhongQi Pharmaceutical Technology...

Not yet recruiting

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Breast Cancer

China
Beijing Tiantan Hospital
Jiangsu Wangao Pharmaceutical Co. ltd

Recruiting

GD-11 for Injection in the Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

China
Zhejiang Cancer Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

Female Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
Yantai Yuhuangding Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer

Breast Cancer

China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Changhai Hospital

Not yet recruiting

A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Crohn's Disease | Perianal Fistula
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bristol-Myers Squibb

Unknown

A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis (RA)

China
Tang-Du Hospital
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Unknown

Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis

Liver Dysfunction

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Nanjing Medical University

Completed

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B (PEG-Tα1)

Hepatitis B, Chronic

China
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Recruiting

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

China
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Australia
Fujian Cancer Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma (ARISE)

Pulmonary Adenosquamous Carcinoma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
G1 Therapeutics, Inc.

Completed

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Extensive-Stage Small Cell Lung Cancer Patients Receiving Carboplatin Combined With Etoposide or Topotecan

Extensive-stage Small-cell Lung Cancer

China
Beijing Anzhen Hospital
Jiangsu Kangyuan Pharmaceutical Co. Ltd

Unknown

DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris

Coronary Artery Disease

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Nanjing Medical University

Unknown

Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B (PEG-Tα1)

Hepatitis B, Chronic

China
Henan Cancer Hospital
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Non-small Cell Lung Cancer

China
Jinling Hospital, China
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Pancreatic Cancer | Neoadjuvant Therapy

China
Xuanwu Hospital, Beijing
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica Spectrum Disorder
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Advanced Solid Tumors

United States
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Recruiting

ASKB589 in Combination With CAPOX and Sintilimab in Patients With Advanced, and Unresectable G/GEJ Cancer.

Gastric Cancer

China
AskGene Pharma, Inc.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Recruiting

A Study of ASKG315 in Patients With Advanced Solid Tumors.

Advanced Solid Tumors

China
Shanghai Chest Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Treatment (ACTIVE)

Lung Cancer | EGFR Gene Mutation
Zhejiang Cancer Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases (ACHIEVE)

Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
G1 Therapeutics, Inc.

Completed

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Extensive-stage Small-cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bristol-Myers Squibb

Unknown

Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

Rheumatoid Arthritis (RA)
Hunan Cancer Hospital
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Recruiting

A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Hepatocellular Carcinoma | Immune Checkpoint Inhibitors

China

Clinical Trials Sponsored by Jiangsu Kanion Pharmaceutical Co.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations